carbamazepine has been researched along with Hyperplasia, Reactive Lymphoid in 9 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We described a 29-year-old Japanese woman with a pseudolymphoma syndrome due to carbamazepine." | 7.70 | Pseudolymphoma syndrome due to carbamazepine. ( Etoh, T; Mihm, MC; Saeki, H; Toda, K, 1999) |
| "A 44-year-old woman known to be allergic to phenytoin was treated with carbamazepine for 1 month and developed fever, lymphadenopathy, pneumonitis, hepatitis, and a morbilliform eruption." | 3.70 | Carbamazepine-induced pseudolymphoma with CD-30 positive cells. ( Belsito, DV; Nathan, DL, 1998) |
| "We described a 29-year-old Japanese woman with a pseudolymphoma syndrome due to carbamazepine." | 3.70 | Pseudolymphoma syndrome due to carbamazepine. ( Etoh, T; Mihm, MC; Saeki, H; Toda, K, 1999) |
| " We discuss the differential diagnosis of atypical CD30+ infiltrates in this setting, which include recurrent lymphoma or myeloid leukemia, primary cutaneous anaplastic large cell lymphoma (ALCL), lymphomatoid papulosis (LyP), carbamazepine-induced CD30+ pseudolymphoma, viral infection and an atypical eruption of lymphocyte recovery." | 3.70 | Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions. ( Duncan, LM; Su, LD, 2000) |
| " Following treatment with antiepileptic drugs (AEDs), the patient developed several rare complications: after beginning therapy with phenytoin, the patient developed pseudolymphoma; after monotherapy with carbamazepine (CBZ), the patient thereafter developed myoclonic jerks of upper and lower limbs upon awakening; after one year of treatment with valproate (VPA) the patient developed clinical and immuno-haematological signs of SLE." | 3.69 | Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p. ( Diomedi, M; Gigli, GL; Masala, C; Placidi, F; Pomponi, MG; Scalise, A; Silvestri, G, 1996) |
| "Carbamazepine was stopped and the lesions disappeared without relapse over a 4-year follow-up." | 1.31 | Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. ( Beylot, C; Beylot-Barry, M; Cogrel, O; Doutre, MS; Dubus, P; Merlio, JP; Vergier, B, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Etesami, I | 1 |
| Kalantari, Y | 1 |
| Tavakolpour, S | 1 |
| Mahmoudi, H | 1 |
| Daneshpazhooh, M | 1 |
| Sueki, H | 1 |
| Sasaki, M | 1 |
| Kamiyama, T | 1 |
| Ohtoshi, S | 1 |
| Watanabe, H | 1 |
| Nakada, T | 1 |
| Gigli, GL | 1 |
| Scalise, A | 1 |
| Silvestri, G | 1 |
| Diomedi, M | 1 |
| Placidi, F | 1 |
| Pomponi, MG | 1 |
| Masala, C | 1 |
| Paramesh, H | 1 |
| Satish, DA | 1 |
| Khatib, SA | 1 |
| Jain, M | 1 |
| Nathan, DL | 1 |
| Belsito, DV | 1 |
| d'Incan, M | 1 |
| Mouillet, ML | 1 |
| Roger, H | 1 |
| Ferrier, MC | 1 |
| Buono, JP | 1 |
| Déchelotte, P | 1 |
| Bignon, YJ | 1 |
| Souteyrand, P | 1 |
| Saeki, H | 1 |
| Etoh, T | 1 |
| Toda, K | 1 |
| Mihm, MC | 1 |
| Su, LD | 1 |
| Duncan, LM | 1 |
| Cogrel, O | 1 |
| Beylot-Barry, M | 1 |
| Vergier, B | 1 |
| Dubus, P | 1 |
| Doutre, MS | 1 |
| Merlio, JP | 1 |
| Beylot, C | 1 |
1 review available for carbamazepine and Hyperplasia, Reactive Lymphoid
| Article | Year |
|---|---|
Drug-induced cutaneous pseudolymphoma: A systematic review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Anticonvulsants; Antihypertensiv | 2023 |
8 other studies available for carbamazepine and Hyperplasia, Reactive Lymphoid
| Article | Year |
|---|---|
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma.
Topics: Adult; Antimanic Agents; Carbamazepine; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Hum | 2014 |
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p.
Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Chromosome Aberrations; Chromosome Disorders; Chromoso | 1996 |
Carbamazepine induced pseudolymphoma syndrome.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Humans; Male; Pseudolymphoma; Seizures; Syndrome | 1997 |
Carbamazepine-induced pseudolymphoma with CD-30 positive cells.
Topics: Adult; Anticonvulsants; Antigens, CD20; Biopsy; Carbamazepine; CD3 Complex; Chemical and Drug Induce | 1998 |
[Cutaneous pseudolymphoma caused by carbamazepine].
Topics: Adult; Carbamazepine; Drug Eruptions; Female; Humans; Pseudolymphoma; Skin Diseases; Thorax | 1998 |
Pseudolymphoma syndrome due to carbamazepine.
Topics: Adult; Antimanic Agents; Blotting, Southern; Carbamazepine; Diagnosis, Differential; Facial Dermatos | 1999 |
Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.
Topics: Carbamazepine; Diagnosis, Differential; Female; Humans; Immunoenzyme Techniques; Ki-1 Antigen; Leuke | 2000 |
Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Eruptions; Humans; Male; Pseudolymphoma; Recurrence; Val | 2001 |